Bioequivalence Studies of Omnitrope, the First Biosimilar/rhGH Follow-on Protein: Two Comparative Phase 1 Randomized Studies and Population Pharmacokinetic Analysis-Reference-Cited by-同舟云学术

Bioequivalence Studies of Omnitrope, the First Biosimilar/rhGH Follow-on Protein: Two Comparative Phase 1 Randomized Studies and Population Pharmacokinetic Analysis

Published:2010-11 Issue:11 Volume:50 Page:1339-1348
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Stanhope Richard,Sörgel Fritz,Gravel Patricia,Schuetz Yannic B. Pannatier,Zabransky Markus,Muenzberg Michael

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH;Bengtsson;J Clin Endocrinol Metab,1993

2. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline;Molitch;J Clin Endocrinol Metab,2006

3. Effect of long-term recombinant growth hormone therapy in children-the National Cooperative Growth Study, USA, 1985-1994;Root;J Pediatr Endocrinol Metab,1998

4. Effects of growth hormone in patients with chronic renal failure: experience in children and adults;Wuhl;Horm Res,2002

5. Growth hormone axis in chronic kidney disease;Mahesh;Pediatr Nephrol,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?;Drug Design, Development and Therapy;2024-02

2. Characterization of the aggregation propensity of charge variants of recombinant human growth hormone;International Journal of Pharmaceutics;2022-06

3. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals;BioDrugs;2019-03-04

4. Utilization of data below the analytical limit of quantitation in pharmacokinetic analysis and modeling: promoting interdisciplinary debate;Bioanalysis;2018-08-01

5. Relative Bioavailability of a Single 4-mg Dose of Somatropin Administered by Subcutaneous Injection or by Needle-free Device and Coadministered With the Growth Hormone Inhibitor Octreotide Acetate in Healthy Adult Subjects;Clinical Therapeutics;2018-05